Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy. [electronic resource]
Producer: 20070416Description: 201-10 p. digitalISSN:- 0937-941X
- Administration, Oral
- Aged
- Aged, 80 and over
- Alendronate -- administration & dosage
- Biomarkers -- analysis
- Bone Density -- physiology
- Bone Density Conservation Agents -- administration & dosage
- Bone Diseases, Metabolic -- complications
- Bone and Bones -- physiopathology
- Cost-Benefit Analysis -- methods
- Diphosphonates -- administration & dosage
- Female
- Fractures, Bone -- etiology
- Humans
- Markov Chains
- Middle Aged
- Postmenopause -- physiology
- Quality-Adjusted Life Years
- Risk Factors
- Spinal Fractures -- etiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.